Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	194.24	194.92	190.13	174.21	207.5	185.45
Other Revenue	-	-	0.02	0.01	1.19	0.11
Revenue	194.24	194.92	190.14	174.22	208.69	185.56
Revenue Growth (YoY)	0.91%	2.51%	9.14%	-16.52%	12.46%	-1.35%
Cost of Revenue	44.75	45.8	49.84	33.5	36.33	35.3
Gross Profit	149.49	149.11	140.3	140.72	172.36	150.27
Selling, General & Admin	75.91	76.71	74.35	73.71	62.81	52.62
Research & Development	20.82	23.84	30.41	15.46	25.76	22.52
Other Operating Expenses	3.8	1.68	1.53	1.21	1.45	-3.25
Operating Expenses	101.29	102.96	107.08	90.28	90.34	71.56
Operating Income	48.2	46.15	33.22	50.45	82.03	78.71
Interest Expense	-0.32	-0.43	-0.65	-0.68	-0.71	-
Interest & Investment Income	7.54	6.12	10.62	16.3	1.48	2.33
Currency Exchange Gain (Loss)	-0.03	-0.03	0.12	0.49	-0.12	-
Other Non Operating Income (Expenses)	0.17	0.23	-0.25	0.42	-0.3	-0.96
EBT Excluding Unusual Items	55.56	52.04	43.06	66.97	82.38	80.09
Gain (Loss) on Sale of Investments	-6.23	-4.97	2.59	2.62	-0.79	-5.34
Gain (Loss) on Sale of Assets	0.41	0.41	-0.01	-0.07	-0.25	-
Asset Writedown	-0.1	-	-	-	-	-
Other Unusual Items	3.17	3.09	-0.23	4.53	6.54	-
Pretax Income	52.82	50.57	45.42	74.04	87.88	74.75
Income Tax Expense	6.24	6.28	6.64	9.84	11.39	11.58
Earnings From Continuing Operations	46.57	44.29	38.77	64.2	76.48	63.17
Net Income	46.57	44.29	38.77	64.2	76.48	63.17
Net Income to Common	46.57	44.29	38.77	64.2	76.48	63.17
Net Income Growth	25.08%	14.23%	-39.60%	-16.06%	21.07%	-3.93%
Shares Outstanding (Basic)	102	108	108	102	81	81
Shares Outstanding (Diluted)	102	108	108	102	81	81
Shares Change (YoY)	-14.22%	0.30%	5.70%	25.24%	0.46%	-0.23%
EPS (Basic)	0.45	0.41	0.36	0.63	0.94	0.78
EPS (Diluted)	0.45	0.41	0.36	0.63	0.94	0.78
EPS Growth	45.81%	13.89%	-42.86%	-32.98%	20.51%	-3.70%
Free Cash Flow	-4.7	-9.12	4.15	41.46	64.68	80.43
Free Cash Flow Per Share	-0.05	-0.08	0.04	0.41	0.80	0.99
Dividend Per Share	0.320	0.320	0.200	0.750	0.900	-
Dividend Growth	60.00%	60.00%	-73.33%	-16.67%	-	-
Gross Margin	76.96%	76.50%	73.79%	80.77%	82.59%	80.98%
Operating Margin	24.82%	23.68%	17.47%	28.96%	39.30%	42.42%
Profit Margin	23.98%	22.72%	20.39%	36.85%	36.65%	34.04%
Free Cash Flow Margin	-2.42%	-4.68%	2.18%	23.79%	30.99%	43.34%
EBITDA	68.33	65.5	49.46	64.43	96.15	-
EBITDA Margin	35.18%	33.61%	26.01%	36.98%	46.07%	-
D&A For EBITDA	20.13	19.36	16.24	13.98	14.12	-
EBIT	48.2	46.15	33.22	50.45	82.03	78.71
EBIT Margin	24.82%	23.68%	17.47%	28.96%	39.30%	42.42%
Effective Tax Rate	11.82%	12.41%	14.62%	13.29%	12.97%	15.49%
Revenue as Reported	194.24	194.92	190.14	174.22	208.69	185.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.